Detalhe da pesquisa
1.
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma.
N Engl J Med
; 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38828933
2.
Smouldering multiple myeloma: To seek or not to seek? To treat or not to treat. That is the question.
Br J Haematol
; 204(4): 1141-1142, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429858
3.
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
N Engl J Med
; 385(1): 46-58, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192431
4.
Amyloidogenic light chains impair plasma cell survival.
Haematologica
; 108(12): 3359-3371, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381778
5.
Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial.
Haematologica
; 108(7): 1827-1839, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200421
6.
Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity-induced rash in patients with multiple myeloma.
Eur J Haematol
; 110(4): 407-413, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36565290
7.
Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma.
Haematologica
; 107(10): 2395-2407, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35354252
8.
Monitoring Minimal Residual Disease in RUNX1-Mutated Acute Myeloid Leukemia.
Acta Haematol
; 145(6): 642-649, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35933982
9.
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial.
Lancet
; 396(10262): 1563-1573, 2020 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33189178
10.
Neurological misdiagnoses of lymphoma.
Neurol Sci
; 42(5): 1933-1940, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32974798
11.
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study.
Ann Hematol
; 99(6): 1273-1281, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32193630
12.
Evaluation of cerebrospinal clonal gene rearrangement in newly diagnosed non-Hodgkin's lymphoma patients.
Ann Hematol
; 98(11): 2561-2567, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515574
13.
Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell Lymphoma.
Acta Haematol
; 141(4): 216-221, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943470
14.
The use of serum free light chain dimerization patterns assist in the diagnosis of AL amyloidosis.
Br J Haematol
; 182(1): 86-92, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29767409
15.
Do older patients truly benefit from advances in myeloma care?
Haematologica
; 108(6): 1470-1472, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36300777
16.
Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis.
Eur J Haematol
; 100(5): 494-501, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29453884
17.
Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective study.
Am J Hematol
; 93(6): 810-815, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29603773
18.
A Bortezomib-Based Protocol Induces a High Rate of Complete Remission with Minor Toxicity in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
Acta Haematol
; 140(4): 209-214, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30343286
19.
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy.
Am J Hematol
; 92(2): 131-135, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27804150
20.
Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study.
Br J Haematol
; 172(1): 89-96, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26567759